glp-1 and ampk Metformin Glucagon-like peptide-1 (GLP-1) inhibit Adenosine GLP-1R interrelates with the AMPK/mTOR

In 2012, a compounding pharmacy caused a fungal meningitis outbreak that killed at least 64 people, among the worst pharmaceutical drug-contamination disasters in the United States

PMID: 15176951

Additionally, CPT1C enhances ceramide expression and upregulates NPY and AgRP expression and secretion while downregulating POMC expression in the ARC of the hypothalamus, thereby promoting appetite

Research in earlier phases or small trials include evaluation of GLP-1s for cystic fibrosis-related diabetes, polycystic ovarian syndrome (PCOS), chronic obstructive pulmonary disease (COPD), Prader-Willi syndrome (PWS), asthma, substance or alcohol use disorder and as add-on to insulin for type 1 diabetes